Syed Omar Ahmad, OTD, Ph.D.

Dr. Syed Omar Ahmad, OTD, Ph.D.

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 June 2013 in Neuroscience Letters
Verified
Journal Article
Closed access
MHMichelle Healy-Stoffel
Michelle Healy-Stoffel
SPSyed Omar Ahmad, OTD, Ph.D.
Syed Omar Ahmad, OTD, Ph.D.
JSJohn A. Stanford
John A. Stanford
BLBeth Levant
Beth Levant


25 May 2022 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
NPNicole K. Polinski
Nicole K. Polinski
TMTerina N. Martinez
Terina N. Martinez
SRSylvie Ramboz
Sylvie Ramboz
MSMichael Sasner
Michael Sasner
MHMark Herberth
Mark Herberth
MFMark A. Frasier
Mark A. Frasier
Heterozygous mutations in the GBA1 gene – encoding lysosomal glucocerebrosidase (GCase) – are the most common genetic risk factors for Parkinson's disease (PD). Experimental evidence suggests a correlation between decreased GCase activity and accumulation of alpha-synuclein (aSyn). To enable a better understanding of the relationship between aSyn and GCase activity, we developed and characterized two mouse models that investigate aSyn pathology in the context of reduced GCase activity. The first model used constitutive overexpression of wild-type human aSyn in the context of the homozygous GCase activity-reducing D409V mutant form of GBA1. Although increased aSyn pathology and grip strength reductions were observed in this model, the nigrostriatal system remained largely intact. The second model involved injection of aSyn preformed fibrils (PFFs) into the striatum of the homozygous GBA1 D409V knock-in mouse model. The GBA1 D409V mutation did not exacerbate the pathology induced by aSyn PFF injection. This study sheds light on the relationship between aSyn and GCase in mouse models, highlighting the impact of model design on the ability to model a relationship between these proteins in PD-related pathology.

3 March 2023 in Neuroscience Letters
Verified
Journal Article
Closed access
SPSyed Omar Ahmad, OTD, Ph.D.
Syed Omar Ahmad, OTD, Ph.D.
JLJason K Longhurst
Jason K Longhurst
DSDana Stiles
Dana Stiles
LDLana Downard
Lana Downard
SMStephanie Martin
Stephanie Martin

1 December 2019 in Heliyon
Verified
Journal Article
Open access
SPSyed Omar Ahmad, OTD, Ph.D.
Syed Omar Ahmad, OTD, Ph.D.
JBJ. Baun
J. Baun
BTB. Tipton
B. Tipton
YTY. Tate
Y. Tate
RSR.C. Switzer
R.C. Switzer
Various stains have been devised to reveal degenerative or reactive cell phenotypes, or the disintegrative and/or neuropathic lesions associated with Alzheimer's, Parkinson's, and Pick's diseases, Down's syndrome, or chemical toxicity. Utilization of silver staining has allowed researchers to elucidate neural pathways promoting a greater understanding of the functional connections between brain regions. All of these methods employing silver can be characterized as 'directed staining technologies'. The argyrophilic proteins (AgNOR) staining protocol was modified to stain nucleoli in thick sections prepared for stereological evaluation of brain tissue. Nucleoli appeared as black dots against a pale amber background. Tissue sections were counterstained with Toluidine Blue, or reduced-strength Tyrosine Hydroxylase immunohistochemistry to facilitate visualization of basic cellular morphology and regional nucleus identification. Here, we present a modified method for nucleolar staining in free-floating thick sections of brain embedded in a gelatin matrix. The modifications in our procedure include incubation in HCl to denature ('unravel') the DNA, a bleaching step to reduce non-specific background silver staining, and counterstaining with Toluidine Blue or reduced-strength tyrosine hydroxylase immunohistochemistry. Prior to the development of immunohistochemistry, silver staining was used primarily to identify pathological profiles and trace axon pathways; however, in many cases, a combination of silver staining and immunohistochemistry are required to fully visualize pathomorphology. The mechanism of these stains requires the binding of silver ions to cellular components and the subsequent reduction of the ions to metallic silver. Dilutions of TH primary antibody were evaluated to maximize identification of neurons and the nucleolus amongst the soma and processes present in the thick section. The use of stereology as a tool to estimate cell number has become increasingly prevalent in neuroscience experiments. As requirements for the preparation of experimental tissue have been refined, researchers have begun to use thicker sections, between 40 to 80 microns, to increase the number of optical planes available for analysis. These thick sections require modified staining protocols to assure complete penetration of stains throughout the tissue section. This method is particularly useful in nucleolar identification for Stereology, and automated counting methods. Use of the nucleolus avoids some of the problems associated with use of the nucleus. The nucleolus is smaller than the nucleus and is less susceptible to transection during sectioning. It has a higher density than the nucleus and is easier to visualize. It is generally darker staining than the immunohistochemical reaction product that provides the identification marker for the cells to be counted. Examples of the method in several brain sections of the rat are shown, though the method has been also proven in other mammalian models.